Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Fibrocell Science Inc

+ Add to Watchlist

FCSC:US

3.4600 USD 0.1100 3.28%

As of 20:10:00 ET on 05/01/2015.

Snapshot for Fibrocell Science Inc (FCSC)

Open: 3.3500 Day's Range: 3.2500 - 3.4800 Volume: 91,119
Previous Close: 3.3500 52wk Range: 2.2801 - 5.9900 1-Yr Rtn: +9.49%

Stock Chart for FCSC

No chart data available.
  • FCSC:US 3.4600
  • 1D
  • 1M
  • 1Y
3.3500
Interactive FCSC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FCSC

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6725
Est. EPS (USD) (12/2015) -0.5750
Est. PEG Ratio -
Market Cap (M USD) 141.47
Shares Outstanding (M) 40.89
30 Day Average Volume 108,555
Price/Book (mrq) 4.6488
Price/Sale (ttm) 784.0099
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FCSC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FCSC

Fibrocell Science, Inc. is a biotechnology company that develops skin and tissue rejuvenation technologies. The Company's process multiplies the patient's collagen producing cells and returns them to the patient's skin to treat damage caused by aging, the sun, acne, and burns.

David M PernockChairman/CEOKeith Alan GoldanSenior VP/CFO/Treasurer/Secy
Kimberly M SmithControllerLaura CampbellVP:HR & Business Process
More Company Profile & Key Executives for FCSC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil